News From The Journal Of Clinical Investigation: Oct. 10, 2011
10/11/2011

ONCOLOGY: Can we predict tumor spread to the liver? A common cause of cancer-related death in individuals with colorectal cancer - the second leading cause of death from cancer in the United States - is spreading of the cancer to the liver...

Combination Therapies For Drug-Resistant Cancers
10/11/2011

Some cancers can be effectively treated with drugs inhibiting proteins known as receptor tyrosine kinases, but not those cancers caused by mutations in the KRAS gene...

Potential Biologic Therapies That Specifically Target Metastasis
10/11/2011

Researchers at the Medical College of Wisconsin have shown that a protein can inhibit metastasis of colon and melanoma cancers. The findings are published in the October 10, 2011 issue of Proceedings of the National Academy of Sciences. Michael B. Dwinell, Ph.D...

News From The Journal Of Clinical Investigation: Oct. 10, 2011
10/11/2011

ONCOLOGY: Can we predict tumor spread to the liver? A common cause of cancer-related death in individuals with colorectal cancer - the second leading cause of death from cancer in the United States - is spreading of the cancer to the liver...

Combination Therapies For Drug-Resistant Cancers
10/11/2011

Some cancers can be effectively treated with drugs inhibiting proteins known as receptor tyrosine kinases, but not those cancers caused by mutations in the KRAS gene...

Oral Cancer Recurrence Predicted By Gene Signature
10/11/2011

Oral Squamous Cell Carcinoma (OSCC) is responsible for nearly a quarter of all head and neck cancers. It is one of the leading causes of cancer death - largely due to the failure of current histological procedures in predicting the recurrence of the disease...

KRN5500 Demonstrated Significant Decrease In The Intensity Of Neuropathic Pain In Patients With Cancer
10/11/2011

DARA BioSciences, Inc. (NASDAQ:DARA) announced the Journal of Pain and Symptom Management, an internationally respected, peer-reviewed journal, has published results of a Phase II safety and efficacy study of KRN5500 for the treatment of neuropathic pain in patients with cancer...

CWRU Receives $5.4M Grant To Study Esophageal Cancer
10/11/2011

Case Western Reserve University School of Medicine and the Case Comprehensive Cancer Center are proud to announce the receipt of a highly competitive $5.4 million grant to study genetic determinants of Barrett's esophagus and esophageal adenocarcinoma...

Almost Half Of Cancer Survivors Have Ill Health In Later Years
10/11/2011

Forty-five per cent of cancer survivors in Northern Ireland suffer from physical and mental health problems years after their treatment has finished, according to new research from Macmillan Cancer Support and Queen's University Belfast...

New Strategy To Accelerate Blood Vessel Maturation Has Therapeutic Potentials For Ischemic Diseases
10/11/2011

In Nature, VIB-K.U.Leuven researchers describe a new mechanism to enhance the restoration of the blood flow in ischemic diseases, which are among the leading causes of death worldwide. The team of Massimiliano Mazzone demonstrates that blocking the protein PhD2 in white blood cells accelerates the maturation of blood vessels...